HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Ruhstaller Selected Research

Capecitabine (Xeloda)

11/2010Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study.
7/2008Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK.
4/2008Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Ruhstaller Research Topics

Disease

9Breast Neoplasms (Breast Cancer)
10/2021 - 05/2006
8Neoplasms (Cancer)
10/2021 - 07/2008
3Adenocarcinoma
01/2018 - 04/2008
3Carcinoma (Carcinomatosis)
01/2018 - 09/2009
2Esophageal Neoplasms (Esophageal Cancer)
01/2018 - 09/2009
2Disease Progression
01/2017 - 04/2011
2Colorectal Neoplasms (Colorectal Cancer)
07/2008 - 05/2005
1Amenorrhea
09/2017
1Stomach Neoplasms (Stomach Cancer)
11/2010
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2009
1Osteonecrosis (Kienbock's Disease)
12/2008
1Exanthema (Rash)
07/2008
1Rectal Neoplasms (Rectal Cancer)
04/2008

Drug/Important Bio-Agent (IBA)

3Letrozole (Femara)FDA LinkGeneric
10/2021 - 04/2011
3Hormones (Hormone)IBA
10/2021 - 10/2013
3Capecitabine (Xeloda)FDA Link
11/2010 - 04/2008
3Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2008 - 05/2005
2Cetuximab (Erbitux)FDA Link
01/2018 - 07/2008
2Trastuzumab (Herceptin)FDA Link
01/2017 - 04/2011
2Bevacizumab (Avastin)FDA Link
01/2011 - 12/2008
2Cisplatin (Platino)FDA LinkGeneric
11/2010 - 09/2009
1Estrogens (Estrogen)FDA Link
10/2021
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2017
1Triptorelin Pamoate (Trelstar)FDA Link
09/2017
1palbociclibIBA
01/2016
1lonaprisanIBA
10/2013
1Progesterone Receptors (Progesterone Receptor)IBA
10/2013
1Mifepristone (RU 486)FDA Link
10/2013
1onapristoneIBA
10/2013
1Aromatase InhibitorsIBA
04/2011
1Estrogen ReceptorsIBA
04/2011
1liposomal doxorubicin (Doxil)FDA Link
01/2011
11-dodecylpyridoxal (PLD)IBA
01/2011
1matuzumabIBA
11/2010
1Epirubicin (Ellence)FDA LinkGeneric
11/2010
1Docetaxel (Taxotere)FDA Link
09/2009
1taxaneIBA
09/2009
1XELOXIBA
07/2008
1Fluorouracil (Carac)FDA LinkGeneric
05/2005
1Irinotecan (Camptosar)FDA LinkGeneric
05/2005
1Leucovorin (Folinic Acid)FDA Link
05/2005

Therapy/Procedure

11Therapeutics
09/2018 - 05/2006
5Drug Therapy (Chemotherapy)
09/2017 - 09/2009
3Radiotherapy
01/2014 - 04/2008
1Neoadjuvant Therapy
01/2018
1Adjuvant Chemotherapy
09/2017
1Induction Chemotherapy
09/2009